The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Circulating Cytokine/Inhibitor Profiles Reshape the Understanding of the SIRS/CARS Continuum in Sepsis and Predict Mortality
Open accessAbstract
Mortality in sepsis remains unacceptably high and attempts to modulate the inflammatory response failed to improve survival. Previous reports postulated that the sepsis-triggered immunological cascade is multimodal: initial systemic inflammatory response syndrome (SIRS; excessive pro-, but no/low anti-inflammatory plasma mediators), intermediate homeostasis with a mixed anti-inflammatory response syndrome (MARS; both pro- and anti-inflammatory mediators) and final compensatory anti-inflammatory response syndrome (CARS; excessive anti-, but no/low proinflammatory mediators). To verify this, we examined the evolution of the inflammatory response during the early phase of murine sepsis by repetitive blood sampling of septic animals. Increased plasma concentrations of proinflammatory (IL-6, TNF, IL-1β, KC, MIP-2, MCP-1, and eotaxin) and anti-inflammatory (TNF soluble receptors, IL-10, IL-1 receptor antagonist) cytokines were observed in early deaths (days 1–5). These elevations occurred simultaneously for both the pro- and anti-inflammatory mediators. Plasma levels of IL-6 (26 ng/ml), TNF-α (12 ng/ml), KC (33 ng/ml), MIP-2 (14 ng/ml), IL-1 receptor antagonist (65 ng/ml), TNF soluble receptor I (3 ng/ml), and TNF soluble receptor II (14 ng/ml) accurately predicted mortality within 24 h. In contrast, these parameters were not elevated in either the late-deaths (day 6–28) or survivors. Surprisingly, either pro- or anti-inflammatory cytokines were also reliable in predicting mortality up to 48 h before outcome. These data demonstrate that the initial inflammatory response directly correlates to early but not late sepsis mortality. This multifaceted response questions the use of a simple proinflammatory cytokine measurement for classifying the inflammatory status during sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
Beutler, B., Milsark, I. W., & Cerami, A. C. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,352
Safar, P., & Grenvik, A. (1971) · Chest · doi:10.1378/chest.59.5.535 · Cited by 1,989
Sepsis and septic shock—A review of laboratory models and a proposal
Wichterman, K. A., Baue, A. E., & Chaudry, I. H. (1980) · Journal of Surgical Research · doi:10.1016/0022-4804(80)90037-2 · Cited by 1,459
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H., & Benjamin, E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342603 · Cited by 1,241
Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a Mutant Escherichia coli
Ziegler, E. J., McCutchan, J. A., Fierer, J., Glauser, M. P., Sadoff, J. C., Douglas, H., & Braude, A. I. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211113072001 · Cited by 1,046
Sir Isaac Newton, sepsis, SIRS, and CARS
Bone, R. C. (1996) · Critical Care Medicine · doi:10.1097/00003246-199607000-00010 · Cited by 989
HARBARTH, S., HOLECKOVA, K., FROIDEVAUX, C., PITTET, D., RICOU, B., GRAU, G. E., VADAS, L., PUGIN, J., & the Geneva Sepsis Network (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.3.2009052 · Cited by 898
Keel, M., & Trentz, O. (2005) · Injury · doi:10.1016/j.injury.2004.12.037 · Cited by 885
Gogos, C. A., Drosou, E., Bassaris, H. P., & Skoutelis, A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315214 · Cited by 882
Interleukin-1 receptor antagonist reduces mortality from endotoxin shock
Ohlsson, K., Björk, P., Bergenfeldt, M., Hageman, R., & Thompson, R. C. (1990) · Nature · doi:10.1038/348550a0 · Cited by 853
The use of receiver operating characteristic curves in biomedical informatics
Lasko, T. A., Bhagwat, J. G., Zou, K. H., & Ohno-Machado, L. (2005) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2005.02.008 · Cited by 823
Hubbard, W. J., Choudhry, M., Schwacha, M. G., Kerby, J. D., Rue, L. W., Bland, K. I., & Chaudry, I. H. (2005) · Shock · doi:10.1097/01.shk.0000191414.94461.7e · Cited by 792
Epidemiology of Sepsis Syndrome in 8 Academic Medical Centers
Sands, K. E. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550030074038 · Cited by 663
Remick, D. G., Newcomb, D. E., Bolgos, G. L., & Call, D. R. (2000) · Shock · doi:10.1097/00024382-200013020-00004 · Cited by 534
Self-citationLiliensiek, B., Weigand, M. A., Bierhaus, A., Nicklas, W., Kasper, M., Hofer, S., Plachky, J., Gröne, H.-J., Kurschus, F. C., Schmidt, A. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18704 · Cited by 524
Fisher, C. J., Slotman, G. J., Opal, S. M., Pribble, J. P., Bone, R. C., Emmanuel, G., Ng, D., Bloedow, D. C., & Catalano, M. A. (1994) · Critical Care Medicine · doi:10.1097/00003246-199401000-00008 · Cited by 490
SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITY
Oberholzer, A., Oberholzer, C., & Moldawer, L. L. (2001) · Shock · doi:10.1097/00024382-200116020-00001 · Cited by 481
Downregulation of proinflammatory cytokine release in whole blood from septic patients
Ertel, W., Kremer, J., Kenney, J., Steckholzer, U., Jarrar, D., Trentz, O., & Schildberg, F. (1995) · Blood · doi:10.1182/blood.v85.5.1341.bloodjournal8551341 · Cited by 445
Six at Six: Interleukin-6 Measured 6 H After the Initiation of Sepsis Predicts Mortality Over 3 Days
Remick, D. G., Bolgos, G. R., Siddiqui, J., Shin, J., & Nemzek, J. A. (2002) · Shock · doi:10.1097/00024382-200206000-00004 · Cited by 436
Self-citationAcute Inflammatory Response to Endotoxin in Mice and Humans
Copeland, S., Warren, H. S., Lowry, S. F., Calvano, S. E., & Remick, D. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.1.60-67.2005 · Cited by 436
Self-citationRisk and the Efficacy of Antiinflammatory Agents: Retrospective and Confirmatory Studies of Sepsis
Eichacker, P. Q., Parent, C., Kalil, A., Esposito, C., Cui, X., Banks, S. M., Gerstenberger, E. P., Fitz, Y., Danner, R. L., & Natanson, C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-302oc · Cited by 341
Abraham, E., Laterre, P.-F., Garbino, J., Pingleton, S., Butler, T., Dugernier, T., Margolis, B., Kudsk, K., Zimmerli, W., Anderson, P., et al. (2001) · Critical Care Medicine · doi:10.1097/00003246-200103000-00006 · Cited by 293
Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learned
Reinhart, K., & Karzai, W. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00037 · Cited by 288
ERTEL, W., MORRISON, M. H., WANG, P., BA, Z. F., AYALA, A., & CHAUDRY, I. H. (1991) · Annals of Surgery · doi:10.1097/00000658-199108000-00008 · Cited by 251
Mokart, D., Merlin, M., Sannini, A., Brun, J. P., Delpero, J. R., Houvenaeghel, G., Moutardier, V, & Blache, J. L. (2005) · British Journal of Anaesthesia · doi:10.1093/bja/aei143 · Cited by 241
Immunopathologic Alterations in Murine Models of Sepsis of Increasing Severity
Ebong, S., Call, D., Nemzek, J., Bolgos, G., Newcomb, D., & Remick, D. (1999) · Infection and Immunity · doi:10.1128/iai.67.12.6603-6610.1999 · Cited by 221
Self-citationOberholzer, A., Souza, S., Tschoeke, S. K., Oberholzer, C., Abouhamze, A. S., Pribble, J. P., & Moldawer, L. L. (2005) · PubMed · Cited by 219
Neidhardt, R., Keel, M., Steckholzer, U., Safret, A., Ungethuem, U., Trentz, O., & Ertel, W. (1997) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199705000-00017 · Cited by 217
Lekkou, A., Karakantza, M., Mouzaki, A., Kalfarentzos, F., & Gogos, C. A. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.1.161-167.2004 · Cited by 202
Tschaikowsky, K., Hedwig-Geissing, M., Schiele, A., Bremer, F., Schywalsky, M., & Schüttler, J. (2002) · Critical Care Medicine · doi:10.1097/00003246-200205000-00010 · Cited by 182
In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice
Wesche-Soldato, D. E., Chung, C.-S., Lomas-Neira, J., Doughty, L. A., Gregory, S. H., & Ayala, A. (2005) · Blood · doi:10.1182/blood-2004-10-4086 · Cited by 177
Ayala, A., Deol, Z. K., Lehman, D. L., Herdon, C. D., & Chaudry, I. H. (1994) · Journal of Surgical Research · doi:10.1006/jsre.1994.1092 · Cited by 150
Salkowski, C. A., Detore, G. R., Franks, A. K., Falk, M. C., & Vogel, S. N. (1998) · Infection and Immunity · doi:10.1128/iai.66.8.3569-3578.1998 · Cited by 138
Cytokine Therapeutics for the Treatment of Sepsis: Why has Nothing Worked?
Remick, D. G. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033392567 · Cited by 125
Self-citationNovel Therapies for Sepsis: A Review
Deans, K. J., Haley, M., Natanson, C., Eichacker, P. Q., & Minneci, P. C. (2005) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000158244.69179.94 · Cited by 122
Use of Predicted Risk of Mortality to evaluate the efficacy of anticytokine therapy in sepsis
Knaus, W. A., Harrell, F. E., LaBrecque, J. F., Wagner, D. P., Pribble, J. P., Draper, E. A., Fisher, C. J., & Soll, L. (1996) · Critical Care Medicine · doi:10.1097/00003246-199601000-00010 · Cited by 109
Turnbull, I. R., Javadi, P., Buchman, T. G., Hotchkiss, R. S., Karl, I. E., & Coopersmith, C. M. (2004) · Shock · doi:10.1097/01.shk.0000108399.56565.e7 · Cited by 97
IMMUNOPATHOLOGIC RESPONSES TO NON-LETHAL SEPSIS
Ebong, S., Call, D. R., Bolgos, G. L., Newcomb, D. E., Granger, J. I., O’Reilly, M., & Remick, D. G. (1999) · Shock · doi:10.1097/00024382-199908000-00005 · Cited by 96
Self-citationAnti-inflammatory response is associated with mortality and severity of infection in sepsis
Ashare, A., Powers, L. S., Butler, N. S., Doerschug, K. C., Monick, M. M., & Hunninghake, G. W. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00231.2004 · Cited by 94
ANTIBIOTIC TREATMENT INFLUENCES OUTCOME IN MURINE SEPSIS
Newcomb, D. E., Bolgos, G. L., Green, L. B., & Remick, D. G. (1998) · Shock · doi:10.1097/00024382-199808000-00005 · Cited by 92
Self-citationBonville, D. A., Parker, T. S., Levine, D. M., Gordon, B. R., Hydo, L. J., Eachempati, S. R., & Barie, P. S. (2004) · Surgical Infections · doi:10.1089/109629604773860291 · Cited by 91
Heagy, W., Nieman, K. M., Hansen, C., Cohen, M., Danielson, D., & West, M. A. (2003) · Surgical Infections · doi:10.1089/109629603766956960 · Cited by 82
Remick, D. G., Call, D. R., Ebong, S., Newcomb, D. E., Nybom, P., Nemzek, J. A., & Bolgos, G. L. (2001) · Critical Care Medicine · doi:10.1097/00003246-200103000-00001 · Cited by 76
Self-citationEpidemiology of Sepsis Syndrome in 8 Academic Medical Centers
Sands, K., Bates, D. W., Lanken, P. N., GRAMAN, P. S., Hibberd, P. L., Kahn, K. L., PARSONNET, J., Panzer, R. J., Orav, E. J., Snydman, D. R., et al. (1998) · Survey of Anesthesiology · doi:10.1097/00132586-199808000-00010 · Cited by 66
Xiao, H., & Remick, D. G. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000151049.19253.54 · Cited by 66
Self-citationIs Sepsis-Induced Apoptosis Associated with Macrophage Dysfunction?
Ayala, A., Urbanich, M. A., Herdon, C. D., & Chaudry, I. H. (1996) · doi:10.1097/00005373-199604000-00008 · Cited by 62
Terregino, C. A., Lopez, B. L., Karras, D. J., Killian, A. J., & Arnold, G. K. (2000) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(00)70101-6 · Cited by 62
Mechanism of Splenic Immunosuppression During Sepsis: Key Role of Kupffer Cell Mediators
Ayala, A., O’Neill, P. J., Uebele, S. A., Herdon, C. D., & Chaudry, I. H. (1997) · doi:10.1097/00005373-199705000-00019 · Cited by 54
Cited by
Resolvins and protectins in inflammation resolution
Serhan, C. N., & Petasis, N. A. (2011) · Chemical Reviews · doi:10.1021/cr100396c · Cited by 996
Gentile, L. F., Cuenca, A. G., Efron, P. A., Ang, D., Bihorac, A., McKinley, B. A., Moldawer, L. L., & Moore, F. A. (2012) · Journal of Trauma and Acute Care Surgery · doi:10.1097/ta.0b013e318256e000 · Cited by 801
Cecal ligation and puncture: the gold standard model for polymicrobial sepsis?
Dejager, L., Pinheiro, I., Dejonckheere, E., & Libert, C. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.01.001 · Cited by 784
Dickson, R. P., Singer, B. H., Newstead, M. W., Falkowski, N. R., Erb-Downward, J. R., Standiford, T. J., & Huffnagle, G. B. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.113 · Cited by 724
Mei, S. H. J., Haitsma, J. J., Dos Santos, C. C., Deng, Y., Lai, P. F. H., Slutsky, A. S., Liles, W. C., & Stewart, D. J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0010oc · Cited by 721
Metadata
- Authors
- Osuchowski, M. F., Welch, K., Siddiqui, J., & Remick, D. G.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-08-01
- Volume
- 177
- Issue
- 3
- Pages
- 1967-1974
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1606631580
- Cited by
- 510
- References
- 56
- FWCI
- 17.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.